Skip to search formSkip to main contentSkip to account menu

Stage III Lung Adenocarcinoma

Known as: Stage III Adenocarcinoma of Lung, Stage III Lung Adenocarcinoma AJCC v7, Stage III Adenocarcinoma of the Lung 
Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB… 
National Institutes of Health

Related topics

Related topics

27 relations
ALK geneChestChromosome 13q deletionCoughing

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Targeted Therapy Followed by Cytotoxic Chemotherapy in Preoperative Patients With Locally Advanced Lung Adenocarcinoma
Background: Although oncogene-targeted therapy is a first-line treatment for advanced, unresectable lung adenocarcinoma harboring… 
2018
2018
Use of 18F-FDG PET/CT to predict short-term outcomes early in the course of chemoradiotherapy in stage III adenocarcinoma of the lung.
The purpose of the present prospective study was to evaluate the use of 18F-fluorodeoxyglucose positron emission tomography… 
2017
2017
Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein encoded by a gene located in the short arm of chromosome… 
2016
2016
Whole exome sequencing analysis of the neoadjuvant bevacizumab plus pemetrexed and carboplatin for unresectable stage III lung adenocarcinoma: Results of the phase II GASTO 1001 trial.
e20045Background: GASTO 1001 is a phase II trial investigating the efficacy and safety of induction bevacizumab plus chemotherapy… 
2015
2015
Phase II trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
7528 Background: Unresectable stage III non-small cell lung cancer is often treated with concurrent chemoradiotherapy… 
2014
2014
The impact of EGFR mutation on definitive concurrent chemoradiation therapy for inoperable stage III lung adenocarcinoma.
7558 Background: Concurrent chemoradiation therapy (CRT) is the current standard of care for patients with locally advanced lung… 
2012
2012
Recruitment of Podoplanin Positive Cancer-Associated Fibroblasts in Metastatic Lymph Nodes Predicts Poor Prognosis in Pathological N2 Stage III Lung Adenocarcinoma
BackgroundCancer-associated fibroblasts (CAFs) directly communicate with cancer cells and play important roles in cancer… 
2011
2011
Clinical research of pemetrexed/cisplatin concurrent and consolidate chemotherapy cambined with conformal or intensity-modulated radiotherapy for patients with unresectable stage III lung…
Objective To evaluate the efficacy and safety of pemetrexed and cisplatin concurrent and consolidate chemotherapy combined with… 
2011
2011
Abstract 3165: Profiling of circulating tumor-associated autoantibodies for lung adenocarcinoma detection
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Purpose: To identify a panel of tumor associated… 
1995
1995
Botulinum toxin for suspected pseudoachalasia.
We describe a 74-yr-old man with stage III adenocarcinoma of the lung who presented with suspected malignancy-induced secondary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)